Pricing Log in Create free account

Adherex Technologies Inc. (FENC) vs Opus Genetics, Inc. (IRD)

Adherex Technologies Inc. and Opus Genetics, Inc. are both Biotechnology companies. Adherex Technologies Inc. and Opus Genetics, Inc. are of similar size ($362.9M and $336.9M). Adherex Technologies Inc. grew revenue faster over the last twelve months: 77.8% against −36.1%. Adherex Technologies Inc. has the higher net margin (−5.49% vs −1,091.8%) and the lower return on invested capital (−58.9% vs 0.00%). Across the 16 metrics below, Adherex Technologies Inc. leads on 10 and Opus Genetics, Inc. on 6.

Valuation

Metric FENC IRD Biotechnology median
P/E n/m n/m 8.50
P/S 5.82 36.91 9.71
P/B 8.12 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 5.44 31.47 9.21
Earnings yield (1.24%) (33.86%) (33.15%)
Free cash flow yield (0.59%) (11.61%) (25.50%)

Profitability

Metric FENC IRD Biotechnology median
Gross margin 93.73% 100.00% 65.16%
Operating margin (1.90%) (513.47%) 0.00%
Net margin (5.49%) (1,091.82%) 0.00%
Free cash flow margin (3.44%) (412.61%) 0.00%
Return on equity (18.58%) (4,796.52%) (56.36%)
Return on assets (5.39%) (163.50%) (48.04%)
Return on invested capital (58.89%) 0.00% 0.00%

Growth

Metric FENC IRD Biotechnology median
Revenue growth (TTM) 77.83% (36.09%) 6.02%
EPS growth (last fiscal year) (2,087.50%) 62.79% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric FENC IRD Biotechnology median
Debt to equity 0.00 (2.69) 0.00
Current ratio 5.85 12.19 4.72
Net debt to EBITDA 6.02 1.17 0.96

Dividend

Metric FENC IRD Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric FENC IRD Biotechnology median
Market cap 362.94m 336.94m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack